The Claim
A reduction in LDL-C by 1 mmol/L (39 mg/dL) is associated with a 20% reduction in ischemic stroke risk over five years, and this relationship is consistent across both statin and non-statin interventions, although evidence for non-statin interventions is limited.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Lowering LDL cholesterol by 1 mmol/L over five years reduces the risk of ischemic stroke by 20%, regardless of whether the reduction is achieved with statins or other treatments, though data for non-statin treatments is sparse.
See the scientific wording
The reduction in ischemic stroke risk over five years is directly proportional to the degree of LDL-C lowering, with approximately a 20% reduction in stroke risk per 1 mmol/L (39 mg/dL) decrease in LDL-C, and this relationship holds across statin and non-statin interventions, though data for non-statin stroke outcomes are limited.
Lowering LDL cholesterol reduces the buildup of fatty deposits in artery walls, which prevents those deposits from becoming unstable and rupturing. This stops the formation of blood clots that can block brain arteries and cause strokes.
What the research says
1 studyStudy: Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
This study found that lowering bad cholesterol by any method — whether with statins, diet, or surgery — reduces the risk of heart problems, including stroke, by about the same amount as the cholesterol drop. So if cholesterol goes down 20%, stroke risk also drops about 20%, no matter how you lower it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.